<DOC>
	<DOCNO>NCT02850705</DOCNO>
	<brief_summary>Devic 's neuromyelitis optica ( NMO ) rare . Epidemiological demographic data poor , base mainly monocentric cohort . Moreover , NMO might difficult distinguish multiple sclerosis begin atypical incomplete clinical presentation . Therefore , NMO still underdiagnosed . The constitution nationwide prospective cohort , include NMO also clinical syndrome suggestive first episode ( DNMO-spectrum disorder ( SDs ) ) , allow gather critical mass case answer question could address level single centre . Objectives : The main objective describe clinical , radiological biological feature NMO spectrum disorder ( NMO , isolate longitudinally extensive transverse myelitis ( LETM ) , relapse ; isolate atypical optic neuritis ( ON ) ) evolution . The second aim create biobank dedicate NMO ( serum , whole blood RNA DNA extraction , cerebrospinal fluid ) , promote translational research field . Methods : NOMADMUS prospective , multicentre , observational study patient NMOSD related disorder France . Prevalent case include retrospectively follow prospectively . Incident case include disease onset follow prospectively . A minimal set data define synthesize specific paper form derive European database multiple sclerosis ( EDMUS ) form . Patients systematically test regard AQP4-IgG MOG-IgG status . All data centralise EDMUS-derived database Lyon , EDEN software . All case validate classified expert committee .</brief_summary>
	<brief_title>The French Cohort Biobank Devic 's Neuromyelitis Optica Related Neurological Disorders ( NMOSD ) ( NOMADMUS )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Neuromyelitis Optica</mesh_term>
	<mesh_term>Nervous System Diseases</mesh_term>
	<criteria>Definite Devic 's Neuromyelitis Optica NMO accord establish criterion ( Wingerchuk 1999 , Wingerchuk 2006 , International panel 2015 ) high risk syndrome NMOSD , define : recurrent simultaneous optic neuritis , idiopathic single recurrent longitudinally extensive transverse myelitis ( spinal cord lesion see MRI &gt; 3 vertebral segment ) patient test positive AQP4IgG autoantibody MOGIgG autoantibody live France since 5 year minimum</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Neuromyelitis Optica</keyword>
	<keyword>Myelitis</keyword>
	<keyword>Optic Neuritis</keyword>
	<keyword>autoantibody</keyword>
	<keyword>demyelination</keyword>
</DOC>